Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VGHCX vs SHSSX overlap: 57% of top holdings shared

Bottom line

How much do VGHCX and SHSSX overlap?

57% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 46.4% of VGHCX's assets and 51.7% of SHSSX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

VGHCXSHSSX
Weight overlap (top 25)57%
Shared holdings14
Weight in shared holdings46.4%51.7%
Total positions97155
Expense ratio0.33%0.86%
Holdings as ofJul 31, 2026May 29, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)

Holdings VGHCX and SHSSX have in common

Holding% of VGHCX% of SHSSXOverlap
Eli Lilly & Co8.61%12.29%8.61%
Merck & Co Inc5.44%4.94%4.94%
Johnson & Johnson4.83%8.77%4.83%
AstraZeneca PLC4.59%1.21%1.21%
UnitedHealth Group Inc4.05%6.10%4.05%
Edwards Lifesciences Corp2.56%2.51%2.51%
Intuitive Surgical Inc2.52%1.95%1.95%
Vertex Pharmaceuticals Inc2.36%2.74%2.36%
AbbVie Inc2.30%3.94%2.30%
Danaher Corp2.18%2.00%2.00%
Regeneron Pharmaceuticals Inc2.14%0.91%0.91%
Elevance Health Inc1.83%1.56%1.56%
Boston Scientific Corp1.53%1.59%1.53%
Biogen Inc1.46%1.21%1.21%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VGHCX

  1. Gsk Plc — 3.00%
  2. CVS Health Corp — 2.52%
  3. Cencora Inc — 2.47%
  4. Novartis AG — 1.91%
  5. Argenx SE — 1.68%
  6. HCA Healthcare Inc — 1.68%
  7. Ucb Sa — 1.67%
  8. Agilent Technologies Inc — 1.49%
  9. Galderma Group AG — 1.37%
  10. Roche Holding AG — 1.18%
  11. Dexcom Inc — 1.18%

Only in SHSSX

  1. Gilead Sciences Inc — 4.19%
  2. Amgen Inc — 3.37%
  3. Thermo Fisher Scientific Inc — 3.02%
  4. Pfizer Inc — 2.61%
  5. Abbott Laboratories — 1.97%
  6. Teva Pharmaceutical Industries Ltd — 1.87%
  7. Argenx Se — 1.26%
  8. Stryker Corp — 1.15%
  9. Blackrock Funds III — 1.01%
  10. Revolution Medicines Inc — 0.96%
  11. Humana Inc — 0.92%

Asset mix

Asset typeVGHCXSHSSX
Stocks97.6%99.8%
Repurchase agreements2.2%—
Cash & short-term funds0.1%1.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)

Country mix

CountryVGHCXSHSSX
US77.6%93.9%
GB7.6%1.4%
JP4.8%0.2%
CH4.5%1.4%
BE3.4%0.3%
IL—1.9%
DK1.4%—
NL—1.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)

Check another pair

FAQ

How much do VGHCX and SHSSX overlap?
About 57% by weight. 14 securities appear in both funds' top 25 holdings; they make up 46.4% of VGHCX's assets and 51.7% of SHSSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do VGHCX and SHSSX have in common?
The largest shared holdings are Eli Lilly & Co, Merck & Co Inc, Johnson & Johnson, UnitedHealth Group Inc, Edwards Lifesciences Corp.
Should I own both VGHCX and SHSSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, VGHCX or SHSSX?
SHSSX is broader, with 155 positions versus 97 for VGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.